期刊文献+

阿糖胞苷HepDirect前药MB07133的波谱特征与晶体结构 被引量:1

NMR Characteristics and Crystal Structure of Cytarabine Hep Direct Prodrug MB07133
下载PDF
导出
摘要 用1H和13C NMR和多种2D NMR谱表征了阿糖胞苷的磷酸盐或磷酸酯肝靶向前体药物(Hep Direct前药)——MB07133的结构,对其NMR谱进行了归属;用X-射线单晶衍射测定了单晶的晶体结构.讨论了该化合物的波谱数据和晶体结构数据,验证了其结构的正确性并探讨了其化学结构对药物特性的影响. The structure of the title compound (MB07133) was determined by one-dimensional (i.e.,1H and13C NMR) and two-dimensional (i.e.,1H-1H COSY, gHSQC and gHMBC) NMR techniques. The1H and13C NMR chemical shifts were assigned. The crystal structure of the compound was determined using X-ray single crystal diffraction. The spectral feature and crystal structure of the compound, as well as the structure-function relationship with respective to its use as a prodrug, were discussed.
出处 《波谱学杂志》 CAS CSCD 北大核心 2015年第3期518-527,共10页 Chinese Journal of Magnetic Resonance
关键词 核磁共振(NMR) 阿糖胞苷HepDirect前药 MB07133 2D NMR 晶体结构 单晶衍射 NMR, cytarabine HepDirect prodrug, MB07133, 2D NMR, crystal structure,single crystal diffraction
  • 相关文献

参考文献16

  • 1Boyer, Serge H, Sun Z L, et al. Gomez D arabinofuranoside monophosphate for the treatment of hepatocellular carcinoma[J]. J Med Chem, 2006, 49(26): 7 711-7 720.
  • 2Hecker S J, Erion M D. Prodrugs of phosphates and phosphonates[J]. J Med Chem, 2008, 51: 2 328-2 345.
  • 3MacKenna, Deidre A, Montag, et al. Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma[J]. Cancer Chemoth Pharm, 2009, 64(5): 981-991.
  • 4Erion Mark D, Van Poelje, Paul D, et al. Liver-targeted drug delivery using HepDirect prodrugs[J]. J Pharm Exp Ther, 2005, 312(2): 554-560.
  • 5Schultz C. Prodrugs of biologically active phosphate esters[J]. Bioorg Med Chem, 2003, 11: 885-898.
  • 6Krise J P, Stella V J. Prodrugs of phosphates, phosphonates, and phosphinates[J]. Adv Drug Deliv-Rev, 1996, 19: 287-310.
  • 7Sofia M J, Bao D, Chang W, et al. Discovery of a β-d-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleotide prodrug(PSI-7977) for the treatment of hepatitis C virus[J]. J Med Chem, 2010, 53: 7 202-7 218.
  • 8Dang Q, Kasibhatla S R, Jiang T, et al. Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors[J]. J Med Chem, 2008, 51: 4 331-4 339.
  • 9Siddiqui A Q, McGuigan C, Ballatore C, et al. Design and synthesis of lipophilic phosphoramidate d4T-MP prodrugs expressing high potency against HIV in cell culture: structural determinants for in vitro activity and QSAR[J]. J Med Chem, 1999, 42: 4 122-4 128.
  • 10Zhu Z J, Chen H G, Goel O P, et al. Phosphate prodrugs of PD154075[J]. Bioorg Med Chem Lett, 2000, 10: 1 121-1 124.

二级参考文献13

  • 1李英俊,刘素娜,靳焜,彭勤纪,孙淑琴,许永廷,王营.具有潜在抗菌活性的环丙沙星衍生物的NMR谱研究(英文)[J].波谱学杂志,2004,21(3):317-321. 被引量:8
  • 2张建军,马子川,张海峰.丙酮肟^1H核磁共振溶剂效应的研究[J].波谱学杂志,1995,12(2):178-183. 被引量:2
  • 3陈玥,李剑峰,韦亚兵,沈敬山.新药盐酸洛美利嗪的波谱特征与结构确证[J].波谱学杂志,2006,23(3):341-348. 被引量:4
  • 4Simeon S, Rios J I., Villar A. Pharmacological activities of protoberberine alkaloids[J]. Plant Med Phytother, 1989, 23(3): 202- 250.
  • 5Ohiri F C, Verpoorte R, Baerheim Svendsen A. ^1H NMR chemical shift values for aromatic protons in 2,3,9, 10- and 2,3,10,11-tetrasubstituted tetrahydroprotoberberine alkaloids[J]. Planta Med, 1983, 49 : 162- 164.
  • 6Hughes D W, Holland H L, Maclean D B. ^13C magnetic resonance spectra of some isoquinoline alkaloids and related model compounds[J]. Can J Chem, 1976, 54:2 252 -2 260.
  • 7Ning Yongcheng(宁永成).Structural Identification of Organic Compounds and Organic Spectroscopy(有机化合物结构鉴定与有机波谱学研究).2nd ed(第二版)[M].Beijing(北京):Science Press(科学出版社),2001.
  • 8Zhang Zheng-xing(张正行).Organic Spectroscopy(有机光谱分析)[M].Beijing(北京):Science Press(人民卫生出版社),1995.
  • 9Battersby A R, Southgate R, Staunton J, et al. Synthesis of (+)- and (-)-scoulerine and of (+)- and (-) coreximine[J].J Chem Soc C: Organic Chemistry, 1966, (11):1 052-1 057.
  • 10Kanazawa T,Morita T,Harada K,et al.Selective effect of KB-2796,a new calcium entry blocker,on cerebral circulation:a comparative study of the effects of calcium entry blockers on cerebral and peripheral arterial blood flows[J].Journal of Cardiovascular Pharmacology,1990,16(3):430-437.

共引文献5

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部